Scientists at the Agency for Science, Technology and Research (A*STAR) and the Shanghai Institute of Immunology (SII), along with their international collaborators, have dissected the key signaling mechanism driving inflammation in metabolic dysfunction-associated steatohepatitis (MASH), through which they have also uncovered a promising new protein target to combat the fatty liver disease.
Medical Xpress – latest medical and health news stories
